Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CGC Stock Forecast 2026-2027
$1.00
Current Price
$449.08M
Market Cap
Buy 2
Hold 4
Sell 1
Wall St Analyst Ratings
Distance to CGC Price Targets
+75.6%
To High Target of $1.76
+75.6%
To Median Target of $1.76
+75.6%
To Low Target of $1.76
CGC Price Momentum
-2.9%
1 Week Change
-6.5%
1 Month Change
-32.4%
1 Year Change
-12.3%
Year-to-Date Change
-58.0%
From 52W High of $2.38
+18.5%
From 52W Low of $0.84
📊 TOP ANALYST CALLS
Did CGC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Canopy Growth is one of their latest high-conviction picks.
Latest CGC Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, CGC has a neutral consensus with a median price target of $1.76 (ranging from $1.76 to $1.76). The overall analyst rating is Buy (6.9/10). Currently trading at $1.00, the median forecast implies a 75.6% upside. This outlook is supported by 2 Buy, 4 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CGC Analyst Ratings
2
Buy
4
Hold
1
Sell
CGC Price Target Range
Low
$1.76
Average
$1.76
High
$1.76
Current: $1.00
Latest CGC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CGC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 10, 2025 | Benchmark | Mike Hickey | Hold | Upgrade | $N/A |
| Mar 27, 2025 | Zuanic & Associates | Neutral | Initiates | $N/A | |
| Jul 9, 2024 | Piper Sandler | Underweight | Maintains | $N/A | |
| Sep 15, 2023 | B of A Securities | Lisa Lewandowski | Underperform | Maintains | $0.66 |
| Jun 12, 2023 | CIBC | John Zamparo | Underperformer | Maintains | $0.50 |
| May 2, 2023 | Piper Sandler | Michael Lavery | Underweight | Maintains | $1.00 |
| Feb 17, 2023 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $3.20 |
| Nov 7, 2022 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $3.30 |
| Nov 2, 2022 | Bernstein | Nadine Sarwat | Underperform | Initiates | $1.50 |
| Oct 26, 2022 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $3.05 |
| Sep 30, 2022 | Barclays | Gaurav Jain | Underweight | Maintains | $2.00 |
| Aug 8, 2022 | Piper Sandler | Michael Lavery | Underweight | Maintains | $2.50 |
| Jun 30, 2022 | Piper Sandler | Michael Lavery | Underweight | Maintains | $3.00 |
| Jun 8, 2022 | Barclays | Gaurav Jain | Underweight | Maintains | $3.50 |
| May 31, 2022 | Piper Sandler | Michael Lavery | Underweight | Maintains | $4.00 |
| Mar 22, 2022 | Barclays | Underweight | Downgrade | $N/A | |
| Mar 1, 2022 | Barclays | Gaurav Jain | Equal-Weight | Maintains | $9.00 |
| Feb 18, 2022 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $11.00 |
| Dec 22, 2021 | B of A Securities | Lisa Lewandowski | Underperform | Downgrade | $10.00 |
| Dec 20, 2021 | Piper Sandler | Michael Lavery | Underweight | Downgrade | $7.00 |
Canopy Growth Corporation (CGC) Competitors
The following stocks are similar to Canopy Growth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Canopy Growth Corporation (CGC) Financial Data
Canopy Growth Corporation has a market capitalization of $449.08M with a P/E ratio of -0.2x. The company generates $199.14M in trailing twelve-month revenue with a -117.3% profit margin.
Revenue growth is -0.3% quarter-over-quarter, while maintaining an operating margin of -17.6% and return on equity of -48.5%.
Valuation Metrics
Market Cap
$449.08M
Enterprise Value
$187.06M
P/E Ratio
-0.2x
PEG Ratio
0.0x
Price/Sales
1.6x
Growth & Margins
Revenue Growth (YoY)
-0.3%
Gross Margin
+28.8%
Operating Margin
-17.6%
Net Margin
-117.3%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+98.3%
Current Ratio
5.3x
Debt/Equity
33.7x
ROE
-48.5%
ROA
-2.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Canopy Growth Corporation (CGC) Business Model
About Canopy Growth Corporation
What They Do
Develops and sells cannabis and cannabinoid products.
Business Model
The company operates through various segments including Canadian cannabis, international markets, and wellness products, generating revenue from the sale of medicinal and recreational cannabis, as well as related devices. Its diverse brand portfolio targets adult consumers, medical patients, and commercial partners, emphasizing product development and distribution.
Additional Information
Headquartered in Smiths Falls, Ontario, Canopy Growth Corporation is a key player in the global cannabis industry, focusing on brand differentiation and catering to regulated markets.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
960
CEO
Mr. Luc Mongeau
Country
Canada
IPO Year
2018
Website
www.canopygrowth.comCanopy Growth Corporation (CGC) Latest News & Analysis
Latest News
Quick Summary
Canopy Growth's Claybourne's Frosted Flyers won 'Best Infused Pre-Roll' at the 2026 Grow Up Awards, highlighting its product's recognition in the cannabis industry.
Why It Matters
Canopy Growth's award for best infused pre-roll enhances brand reputation and boosts consumer confidence, potentially increasing sales and market share in the competitive cannabis sector.
Source: Business Wire
Market Sentiment:
Neutral
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
10 days ago
Quick Summary
Canopy Growth (CGC) is currently a focus for Zacks.com users, indicating heightened interest and potential market movements to watch for investors.
Why It Matters
Increased attention on Canopy Growth suggests heightened investor interest, potentially influencing its stock performance and market volatility.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Canopy Growth has diluted existing shareholders to fund a recent acquisition, positioning itself as the top medical cannabis company by revenue in Canada.
Why It Matters
Canopy Growth's acquisition increases its market dominance, potentially enhancing revenue and growth prospects, while dilution may affect shareholder value in the short term.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Medical marijuana has been reclassified to Schedule III by the DEA, offering potential accounting benefits, though companies are currently unable to fully capitalize on these changes.
Why It Matters
The reclassification of medical marijuana to Schedule III may enhance financial flexibility for companies, but current inability to capitalize on this change limits immediate investment benefits.
Source: The Motley Fool
Market Sentiment:
Positive
Canopy Growth Still Looks Broken -- But These 3 Numbers Suggest a Turnaround May Be Starting
12 days ago
Quick Summary
Adjusted EBITDA losses decreased significantly, while medical cannabis revenue increased by 15% year-over-year.
Why It Matters
Falling EBITDA losses indicate improving financial health, while a 15% revenue growth in medical cannabis suggests strong market demand, signaling potential for future profitability.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Canopy Growth Corporation (CGC) closed at $1.06, down 1.85% from the previous trading day.
Why It Matters
Canopy Growth's decline to $1.06 signals potential concerns about its performance and market sentiment, impacting investor confidence and future valuation.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About CGC Stock
What is Canopy Growth Corporation's (CGC) stock forecast for 2026?
Based on our analysis of 9 Wall Street analysts, Canopy Growth Corporation (CGC) has a median price target of $1.76. The highest price target is $1.76 and the lowest is $1.76.
Is CGC stock a good investment in 2026?
According to current analyst ratings, CGC has 2 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $1.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CGC stock?
Wall Street analysts predict CGC stock could reach $1.76 in the next 12 months. This represents a 75.6% increase from the current price of $1.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Canopy Growth Corporation's business model?
The company operates through various segments including Canadian cannabis, international markets, and wellness products, generating revenue from the sale of medicinal and recreational cannabis, as well as related devices. Its diverse brand portfolio targets adult consumers, medical patients, and commercial partners, emphasizing product development and distribution.
What is the highest forecasted price for CGC Canopy Growth Corporation?
The highest price target for CGC is $1.76 from at , which represents a 75.6% increase from the current price of $1.00.
What is the lowest forecasted price for CGC Canopy Growth Corporation?
The lowest price target for CGC is $1.76 from at , which represents a 75.6% increase from the current price of $1.00.
What is the overall CGC consensus from analysts for Canopy Growth Corporation?
The overall analyst consensus for CGC is neutral. Out of 9 Wall Street analysts, 2 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $1.76.
How accurate are CGC stock price projections?
Stock price projections, including those for Canopy Growth Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 14, 2026 2:04 PM UTC